{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:27:07Z","timestamp":1787041627863,"version":"build-2736575974"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2025M783572"],"award-info":[{"award-number":["2025M783572"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ejmech.2026.119116","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:26:58Z","timestamp":1782862018000},"page":"119116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Discovery of highly selective and potent CYP1B1 inhibitors for overcoming paclitaxel resistance in A549\/Taxol cells"],"prefix":"10.1016","volume":"317","author":[{"given":"Ting","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujiang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bohou","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningyi","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dihan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9073-4806","authenticated-orcid":false,"given":"Maosheng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejmech.2026.119116_bib1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/03602530902843483","article-title":"Polymorphism of human cytochrome P450 enzymes and its clinical impact","volume":"41","author":"Zhou","year":"2009","journal-title":"Drug Metab. Rev."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119116_bib2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0006-2952(01)00643-8","article-title":"Cytochrome P450 CYP1B1 protein expression: a novel mechanism of anticancer drug resistance","volume":"62","author":"McFadyen","year":"2001","journal-title":"Biochem. Pharmacol."},{"issue":"14","key":"10.1016\/j.ejmech.2026.119116_bib3","first-page":"3026","article-title":"Tumor-specific expression of cytochrome P450 CYP1B1","volume":"57","author":"Murray","year":"1997","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119116_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.canlet.2012.04.021","article-title":"CYP1B1 and hormone-induced cancer","volume":"324","author":"Gajjar","year":"2012","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119116_bib5","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.taap.2012.01.027","article-title":"7,12-Dimethylbenzanthracene induces apoptosis in RL95-2 human endometrial cancer cells: ligand-selective activation of cytochrome P450 1B1","volume":"260","author":"Kim","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"75","key":"10.1016\/j.ejmech.2026.119116_bib6","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.26197","article-title":"Correction: cytochrome P450 1B1 inhibition suppresses tumorigenicity of prostate cancer via caspase-1 activation","volume":"9","author":"Chang","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2026.119116_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115371","article-title":"Functions of the aryl hydrocarbon receptor (AHR) beyond the canonical AHR\/ARNT signaling pathway","volume":"208","author":"Sondermann","year":"2023","journal-title":"Biochem. Pharmacol."},{"issue":"16","key":"10.1016\/j.ejmech.2026.119116_bib8","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.7150\/jca.42669","article-title":"CYP1B1 gene: implications in glaucoma and cancer","volume":"11","author":"Alsubait","year":"2020","journal-title":"J. Cancer"},{"issue":"2","key":"10.1016\/j.ejmech.2026.119116_bib9","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/0003-9861(91)90070-Y","article-title":"Purification and immunological characterization of a novel cytochrome P450 from C3H\/10T1\/2 cells","volume":"286","author":"Pottenger","year":"1991","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejmech.2026.119116_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ctrv.2017.10.013","article-title":"Cancer chemoprevention revisited: cytochrome P450 family 1B1 as a target in the tumor and the microenvironment","volume":"63","author":"D'Uva","year":"2018","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.ejmech.2026.119116_bib11","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.pharmtox.41.1.297","article-title":"Regulation, function, and tissue-specific expression of cytochrome P450 CYP1B1","volume":"41","author":"Murray","year":"2001","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejmech.2026.119116_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2024.170773","article-title":"Long-term cadmium exposure induces epithelial-mesenchymal transition in breast cancer cells by activating CYP1B1-mediated glutamine metabolic reprogramming in BT474 cells and MMTV-Erbb2 mice","volume":"918","author":"Li","year":"2024","journal-title":"Sci. Total Environ."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119116_bib13","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0006-2952(01)00643-8","article-title":"Cytochrome P450 CYP1B1 protein expression: a novel mechanism of anticancer drug resistance","volume":"62","author":"Mcfadyen","year":"2001","journal-title":"Biochem. Pharmacol."},{"issue":"8","key":"10.1016\/j.ejmech.2026.119116_bib14","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1021\/acs.jmedchem.5b00265","article-title":"Design and synthesis of new alpha-Naphthoflavones as cytochrome P450 (CYP) 1B1 inhibitors to overcome docetaxel-resistance associated with CYP1B1 overexpression","volume":"58","author":"Cui","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119116_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.113733","article-title":"Overcoming Taxol-resistance in A549 cells: a comprehensive strategy of targeting P-gp transporter, AKT\/ERK pathways, and cytochrome P450 enzyme CYP1B1 by 4-hydroxyemodin","volume":"171","author":"Lin","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"24","key":"10.1016\/j.ejmech.2026.119116_bib16","doi-asserted-by":"crossref","first-page":"16451","DOI":"10.1021\/acs.jmedchem.2c01306","article-title":"Structure-based drug design and synthesis of novel N-Aryl-2,4-bithiazole-2-amine CYP1B1-Selective inhibitors in overcoming Taxol resistance in A549 cells","volume":"65","author":"Mao","year":"2022","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2026.119116_bib17","doi-asserted-by":"crossref","first-page":"5883","DOI":"10.1021\/acs.jmedchem.4c00164","article-title":"Design of novel 2-Phenylquinazolin-4-amines as selective CYP1B1 inhibitors for overcoming paclitaxel resistance in A549 cells","volume":"67","author":"Yang","year":"2024","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.ejmech.2026.119116_bib18","doi-asserted-by":"crossref","first-page":"13089","DOI":"10.1021\/acs.jmedchem.5c01181","article-title":"Discovery of highly selective CYP1B1 inhibitors","volume":"68","author":"Wang","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119116_bib19","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ejmech.2017.02.032","article-title":"Quinazoline derivatives as selective CYP1B1 inhibitors","volume":"130","author":"Mohd Siddique","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119116_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112895","article-title":"Discovery of heterocycle-containing alpha-naphthoflavone derivatives as water-soluble, highly potent and selective CYP1B1 inhibitors","volume":"209","author":"Dong","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2026.119116_bib21","doi-asserted-by":"crossref","first-page":"5883","DOI":"10.1021\/acs.jmedchem.4c00164","article-title":"Design of novel 2-Phenylquinazolin-4-amines as selective CYP1B1 inhibitors for overcoming paclitaxel resistance in A549 cells","volume":"67","author":"Yang","year":"2024","journal-title":"J. Med. Chem."},{"issue":"36","key":"10.1016\/j.ejmech.2026.119116_bib22","doi-asserted-by":"crossref","first-page":"37942","DOI":"10.1021\/acsomega.4c04507","article-title":"Scalable synthesis of the key fexuprazan intermediate and investigation of a reaction mechanism","volume":"9","author":"Wang","year":"2024","journal-title":"ACS Omega"},{"issue":"7","key":"10.1016\/j.ejmech.2026.119116_bib23","doi-asserted-by":"crossref","first-page":"5736","DOI":"10.1074\/jbc.M110.204420","article-title":"Structural characterization of the complex between alpha-naphthoflavone and human cytochrome P450 1B1","volume":"286","author":"Wang","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"36","key":"10.1016\/j.ejmech.2026.119116_bib24","doi-asserted-by":"crossref","first-page":"20230","DOI":"10.1039\/D1CP02541D","article-title":"Perspective of structural flexibility on selective inhibition towards CYP1B1 over CYP1A1 by \u03b1-naphthoflavone analogs","volume":"23","author":"Wang","year":"2021","journal-title":"Phys. Chem. Chem. Phys."},{"issue":"9","key":"10.1016\/j.ejmech.2026.119116_bib25","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1039\/D4MD00389F","article-title":"Structure-based virtual screening discovers novel PKMYT1 inhibitors","volume":"15","author":"Zhang","year":"2024","journal-title":"RSC Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426005611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426005611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:00:31Z","timestamp":1787040031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426005611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":25,"alternative-id":["S0223523426005611"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119116","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of highly selective and potent CYP1B1 inhibitors for overcoming paclitaxel resistance in A549\/Taxol cells","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119116","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119116"}}